AI assistant
Sending…
PFIZER INC — Director's Dealing 2020
Feb 26, 2020
29831_dirs_2020-02-25_295a508c-9e28-49e1-a21f-743ef6547f8c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2020-02-23
Reporting Person: CANGIALOSI LORETTA V (Sr. Vice President, Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-23 | Common Stock | F | 1574.0000 | $35.7200 | Disposed | 107041.0000 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2666.0000 | Indirect |
Footnotes
F1: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).
F2: Price is the closing price of Pfizer common stock on February 21, 2020.
More from PFIZER INC
Board/Management Information
2026
Jun 18
Board/Management Information
2026
Jun 18
Annual Report
2026
Jun 16
Annual Report
2026
Jun 16
Call Transcript
2026
Jun 8
Call Transcript
2026
Jun 6
Call Transcript
2026
Jun 3
Major Shareholding Notification
2026
May 12
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 5